Two Sigma Investments
CNTA

Two Sigma Investments’s Centessa Pharmaceuticals CNTA Stock Holding History

Two Sigma Investments’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
59,844
+2,400
+4% +$61.4K ﹤0.01% 2620
2025
Q4 		$1.44M Hold
57,444
– – ﹤0.01% 2695
2025
Q3 		$1.39M Sell
57,444
-14,700
-20% -$261K ﹤0.01% 2364
2025
Q2 		$948K Buy
72,144
+56,844
+372% +$720K ﹤0.01% 2287
2025
Q1 		$220K Sell
15,300
-22,600
-60% -$370K ﹤0.01% 2825
2024
Q4 		$635K Sell
37,900
-66,008
-64% -$1.09M ﹤0.01% 2420
2024
Q3 		$1.66M Buy
103,908
+52,108
+101% +$638K ﹤0.01% 1787
2024
Q2 		$468K Sell
51,800
-26,981
-34% -$256K ﹤0.01% 2403
2024
Q1 		$890K Buy
78,781
+62,281
+377% +$590K ﹤0.01% 2024
2023
Q4 		$131K Buy
16,500
+4,900
+42% +$32.9K ﹤0.01% 2915
2023
Q3 		$75.1K Buy
11,600
+500
+5% +$3.42K ﹤0.01% 2773
2023
Q2 		$68.7K Buy
+11,100
New +$52.7K ﹤0.01% 2794
2021
Q3 		– Sell
-9,973
Closed -$222K – 4296
2021
Q2 		$222K Buy
+9,973
New +$234K ﹤0.01% 3722

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Two Sigma Investments's CNTA Position: Q1 2026 in Review

Two Sigma Investments increased its Centessa Pharmaceuticals (CNTA) stake by 4.2% in Q1 2026, buying an estimated $61.4K and bringing the position to 59,844 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Two Sigma Investments first reported a position in CNTA in Q2 2021 and has held it in 13 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Two Sigma Investments held 59,844 shares of Centessa Pharmaceuticals worth $2.38M as of Q1 2026.
  • Two Sigma Investments bought 2,400 Centessa Pharmaceuticals shares in Q1 2026, an estimated $61.4K.
  • Centessa Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2620 holding.
  • Two Sigma Investments first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.